LA
Standard BioTools Inc.
LAB · NASDAQ
$0.74 -2.59% (-$0.02)
1M +18.43%
Market Cap $290.4M
P/E Ratio -
Div. Yield -
ROE 18.16%
Piotroski F-Score Weak
3/9Valuation
76 /100
Cheap P/S 3.43x
P/B 0.54x
P/E N/A
Growth
0 /100
Declining Rev. growth 4.49%
EPS growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Gross margin 49.14%
FCF margin 97.62%
Net margin 103.29%
Quality
2 /100
Poor ROIC 8.25%
Asset turnover 0.13x
ROE 18.16%
Debt
69 /100
Low Debt/Equity 0.05x
Int. coverage -6,591.47x
Current ratio 9.10x
Stability
42 /100
Moderate Beta 1.37x
Profitable years 0
Rev. volatility 57.57%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about LAB
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Michael Egholm
Employees
387
Headquarters
Boston
Upcoming events
03 NOV
Earnings
Upcoming earnings report